| Properties | Information | |
|---|---|---|
| PhytoCAT-ID | PhytoCAT-334 | |
| Phytochemical name or plant extracts | Putranjiva roxburghii Seed Extract | |
| PMID | 32158209 | |
| Literature evidence | A comparative study of Putranjiva roxburghii Wall. seed extract and developed silver nanoparticles (PJSNPs) for improving bioavailability that enhance their anti-cancer activity against HCT-116 (colon carcinoma), PANC-1 (pancreatic carcinoma), MDA-MB 231 (breast carcinoma) cell lines was performed. | |
| IUPAC name | NA | |
| Phytochemicals’ class or type of plant extracts | NA | |
| Source of phytochemicals or plant Extracts | Putranjiva roxburghii | |
| Geographical availability | Assam, Bangladesh, Borneo, Cambodia, East Himalaya, India, Jawa, Laos, Lesser Sunda Is., Malaya, Maluku, Myanmar, Nepal, New Guinea, Pakistan, Sri Lanka, Sulawesi, Thailand, Vietnam, West Himalaya | |
| Plant parts | Seeds | |
| Other cancers | Breast cancer, Pancreatic cancer, Colon cancer | |
| Target gene or protein | NA | |
| Gene or Protein evidence | NA | |
| Target pathways | NA | |
| IC50 | 7.7 mg/mL against MDA-MB 231 | |
| Potency | NA | |
| Cell line/ mice model | PANC-1, MDA-MB 231, HCT-116 | |
| Additional information | The MTT assay and morphological changes observed by various methods indicate that the novel PJSNPs are a better anticancer agent than PJ extract. | |
| PubChem ID | NA | |
| Additional PMIDs | NA | |
| Additional sources of information | https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:355114-1 | |
| Safety | NA |